AdaptHealth Corp.
Stock Forecast, Prediction & Price Target
AdaptHealth Corp. (AHCO) stock Price Target by analysts
$13
Potential upside: 37.56%
AdaptHealth Corp. price prediction
What is AdaptHealth Corp. stock analysts` prediction?
AdaptHealth Corp. stock forecast: Based on 2 Wall Street analysts` predicted price targets for AdaptHealth Corp. in the last 3 months, the avarage price target is $13, with a high forecast of $NaN. The average price target represents a 37.56% change from the last price of $9.45.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
AdaptHealth Corp. stock Price Target by analysts
Full breakdown of analysts given AdaptHealth Corp. price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
David MacDonald Truist Financial | 50% 1/2 | 11 months ago | $12 26.98% upside | $9.8 | StreetInsider | Previous targets (1) |
Eric Coldwell Robert W. Baird | 0% 0/2 | 11 months ago | $14 48.14% upside | $9.07 | StreetInsider | Previous targets (1) |
Eric Coldwell Robert W. Baird | 0% 0/2 | about 1 year ago | $16 69.31% upside | $11.42 | StreetInsider | Previous targets (1) |
Kevin Caliendo UBS | 0% 0/1 | about 1 year ago | $13 37.56% upside | $9.53 | StreetInsider | Previous targets (0) |
Unknown Deutsche Bank | N/A | about 3 years ago | $28 196.29% upside | $21.81 | Benzinga | N/A |
Unknown Truist Financial | N/A | about 3 years ago | $28 196.29% upside | $20.98 | Benzinga | N/A |
Unknown Leerink Partners | N/A | about 3 years ago | $29 206.87% upside | $22.24 | Benzinga | N/A |
David MacDonald Truist Financial | 50% 1/2 | about 3 years ago | $24 153.96% upside | $21 | Pulse 2.0 | Previous targets (1) |
Unknown Truist Financial | N/A | about 3 years ago | $24 153.96% upside | $19.44 | Benzinga | N/A |
AdaptHealth Corp. Financial Estimates
AdaptHealth Corp. Revenue Estimates
AdaptHealth Corp. EBITDA Estimates
AdaptHealth Corp. Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $2.45B N/A | $2.97B 21.02% | $3.20B 7.72% | Avg: $3.50B Low: $3.47B High: $3.54B avg. 9.46% | Avg: $3.73B Low: $3.70B High: $3.76B avg. 6.64% | Avg: $5.43B Low: $5.39B High: $5.47B avg. 45.43% | Avg: $6.20B Low: $6.15B High: $6.25B avg. 14.14% |
Net Income
% change YoY
| $156.17M N/A | $69.31M -55.61% | $-678.89M -1079.42% | Avg: $139.20M Low: $64.52M High: $170.71M avg. 120.50% | Avg: $167.19M Low: $91.40M High: $215.06M avg. 20.10% | Avg: $212.38M Low: $210.28M High: $214.63M avg. 27.02% | Avg: $255.39M Low: $252.86M High: $258.11M avg. 20.25% |
EBITDA
% change YoY
| $481.82M N/A | $541.33M 12.35% | $-171.09M -131.60% | Avg: $450.64M Low: $446.79M High: $455.77M avg. 363.39% | Avg: $480.59M Low: $476.93M High: $484.52M avg. 6.64% | Avg: $698.94M Low: $693.63M High: $704.66M avg. 45.43% | Avg: $797.84M Low: $791.77M High: $804.36M avg. 14.14% |
EPS
% change YoY
| $1.12 N/A | $0.52 -53.57% | -$5.32 -1123.07% | Avg: $0.93 Low: $0.48 High: $1.27 avg. 117.40% | Avg: $1.16 Low: $0.68 High: $1.6 avg. 25.52% | Avg: $1.58 Low: $1.56 High: $1.6 avg. 35.91% | Avg: $1.9 Low: $1.88 High: $1.92 avg. 20.25% |
Operating Expenses
% change YoY
| $220.00M N/A | $227.01M 3.18% | $1.07B 374.84% | Avg: $243.83M Low: $241.75M High: $246.61M avg. -77.37% | Avg: $260.04M Low: $258.06M High: $262.16M avg. 6.64% | Avg: $378.19M Low: $375.31M High: $381.28M avg. 45.43% | Avg: $431.70M Low: $428.41M High: $435.23M avg. 14.14% |
FAQ
What is AdaptHealth Corp. stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 46.97% in 2025-2028.
We have gathered data from 4 analysts. Their low estimate is 64.52M, average is 139.20M and high is 170.71M.
What is AdaptHealth Corp. stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 18.92% in 2025-2028.
We have gathered data from 8 analysts. Their low revenue estimate is $3.47B, average is $3.50B and high is $3.54B.
What is AdaptHealth Corp. stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 49.77% in 2025-2028.
We have gathered data from 4 analysts. Their low earnings per share estimate is $0.48, average is $0.93 and high is $1.27.
What is the best performing analyst?
In the last twelve months 2 analysts have been covering AdaptHealth Corp. stock. The most successful analyst is David MacDonald whose win rate is 50%. He has correctly predicted 1/2 price targets.